江苏汉晨药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
24
NMPA:24
Drug Approvals
Zinc Sulfate and Allantoin Eye Drops
- Product Name
- 硫酸锌尿囊素滴眼液
- Approval Number
- 国药准字H20084000
- Approval Date
- May 5, 2023
NMPA
Lamivudine Oral Solution
- Product Name
- 拉米夫定口服溶液
- Approval Number
- 国药准字H20183379
- Approval Date
- May 5, 2023
NMPA
Levocetirizine Hydrochloride Oral Solution
- Product Name
- 盐酸左西替利嗪口服溶液
- Approval Number
- 国药准字H20183398
- Approval Date
- May 5, 2023
NMPA
Diclofenac Sodium Eye Drops
- Product Name
- 双氯芬酸钠滴眼液
- Approval Number
- 国药准字H20083274
- Approval Date
- Feb 8, 2023
NMPA
Compound Sodium Chloride Eye Drops
- Product Name
- 复方氯化钠滴眼液
- Approval Number
- 国药准字H20065896
- Approval Date
- Feb 19, 2021
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found